Tumor hypoxia is a common feature of prostate tumors associated with the stabilization of hypoxia-inducible-factor 1alpha (HIF-1α) and poor prognosis following radiation therapy. Lack of oxygen at the time of irradiation is associated with radioresistance, but recent reports suggest radioresponse is also modulated by the dynamic nature of tumor hypoxia.
Derek Hennessey, Lynn Martin, Anne Atzberger, Thomas Lynch, Donal Hollywood and Laure Marignol
Download Paper
SPOTLIGHT: Characterization and Biological Validation of Photon FLASH
SPOTLIGHT: Characterization and Biological Validation of Photon FLASH FLASH (Ultra-High Dose Rate) Radiotherapy is an emerging cancer treatment modality that delivers radiation doses in milliseconds rather than minutes with a significant reduction in healthy tissue...




